Date closed: 9/27/2018
Value: C$86 million
On September 27, 2018, MedMen Enterprises Inc. (MedMen) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) completed a bought deal financing (the Offering) of 15,681,818 units (the Units) at a price of C$5.50 per Unit, which included the exercise in full by the Underwriters of their over-allotment option, for aggregate gross proceeds of approximately C$86,250,000.
The Offering was conducted by way of a short form prospectus through a syndicate of underwriters led by Eight Capital and Cormark Securities Inc., as co-lead underwriters, and including GMP Securities L.P.
MedMen, headquartered in Los Angeles, California, is a cannabis company that owns and operates 19 cannabis facilities in cultivation, manufacturing and retail in the United States.